Michael J. Marshall

2.1k total citations
62 papers, 1.7k citations indexed

About

Michael J. Marshall is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Michael J. Marshall has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 26 papers in Oncology and 10 papers in Immunology. Recurrent topics in Michael J. Marshall's work include Bone Metabolism and Diseases (21 papers), Bone health and treatments (20 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Michael J. Marshall is often cited by papers focused on Bone Metabolism and Diseases (21 papers), Bone health and treatments (20 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Michael J. Marshall collaborates with scholars based in United Kingdom, United States and Oman. Michael J. Marshall's co-authors include John Williams, M.W.J. Davie, Helen S. McCarthy, Mark S. Cragg, Ian Holt, Sarah M. Andrew, Emma L. Davies, Julia Middleton, Helen L. Wright and M. Worsfold and has published in prestigious journals such as Science, The Lancet and The Journal of Immunology.

In The Last Decade

Michael J. Marshall

60 papers receiving 1.6k citations

Peers

Akira Kanamori Japan

Benjamin Klein Israel

Barbara D. Smith United States

Emma Moore United States

Ian James United Kingdom

Georges Bellon France

Jeanne E. Anderson United States

Mehdi Tavassoli United States

Chang Suk Suh South Korea

Laura Kennedy Canada

Akira Kanamori Japan View profile →

Citations per field, relative to Michael J. Marshall

Michael J. Marshall · 1×

×1.3 1.1k

MB

×0.9 412

ONCOL

×1.0 209

IMMUN

×1.9 328

OSM

×0.9 137

ECOLO

Citations per year, relative to Michael J. Marshall

Michael J. Marshall · 1×

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by Michael J. Marshall

Since Specialization

Citations

This map shows the geographic impact of Michael J. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Marshall more than expected).

Fields of papers citing papers by Michael J. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Marshall. The network helps show where Michael J. Marshall may publish in the future.

Co-authorship network of co-authors of Michael J. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Marshall. A scholar is included among the top collaborators of Michael J. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Marshall. Michael J. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Development of C1q Affinity Chromatography for the Study of C1q–IgG Interactions	The Journal of Immunology	Michael J. Marshall, Alexander Knaupp et al.	2
2	Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering	Communications Biology	H.T. Claude Chan, Michael J. Marshall et al.	12
3	The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo	The Journal of Immunology	Sylvia Herter, Laura S. Grosmaire et al.	14
4	Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?	Frontiers in Immunology	Michael J. Marshall, Mark S. Cragg et al.	112
5	Dickkopf-1 as a potential therapeutic target in Paget's disease of bone	Expert Opinion on Therapeutic Targets	Helen S. McCarthy, Michael J. Marshall	16
6	Auto-adjusting positive airway pressure in children with sickle cell anemia: results of a phase I randomized controlled trial	Haematologica	Michael J. Marshall, Romola S. Bucks et al.	37
7	Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells	Bone	Stefan Bajada, Michael J. Marshall et al.	79
8	Increased circulating Dickkopf-1 in Paget's disease of bone	Clinical Biochemistry	Michael J. Marshall, Christopher Sharp et al.	29
9	Platelet‐derived growth factor stimulates osteoprotegerin production in osteoblastic cells	Journal of Cellular Physiology	Helen S. McCarthy, John Williams et al.	22
10	Heat shock proteins form part of a danger signal cascade in response to lipopolysaccharide and GroEL	Clinical & Experimental Immunology	Emma L. Davies, Michael J. Marshall et al.	42
11	Analysis of Osteoclast Function in Mouse Calvarial Cultures	Humana Press eBooks	Michael J. Marshall et al.	3
12	Integrin subunit β3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface	Journal of Cellular Physiology	Ian Holt, Michael J. Marshall	14
13	Inhibition of prostaglandin synthesis leads to a change in adherence of mouse osteoclasts from bone to periosteum	Calcified Tissue International	Michael J. Marshall, Ian Holt et al.	8
14	The number of tartrate-resistant acid phosphatase-positive osteoclasts on neonatal mouse parietal bones is decreased when prostaglandin synthesis is inhibited and increased in response to prostaglandin E2, parathyroid hormone, and 1,25 dihydroxyvitamin D3	Calcified Tissue International	Michael J. Marshall, Ian Holt et al.	13
15	Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones	Calcified Tissue International	Ian Holt, M.W.J. Davie et al.	24
16	Pamidronate stimulates recruitment and decreases longevity of osteoclast nuclei in mice	Seminars in Arthritis and Rheumatism	Ian Holt, Michael J. Marshall et al.	6
17	Requests for medications during chemical dependency rehabilitation as a predictor of relapse	Journal of Substance Abuse	Michael J. Marshall et al.	1
18	An immunocytochemical method for studying the kinetics of osteoclast nuclei on intact mouse parietal bone	The Histochemical Journal	Michael J. Marshall, M.W.J. Davie	8
19	Species Profiles. Life Histories and Environmental Requirements of Coastal Fishes and Invertebrates (South Florida). STONE CRAB	FWS/OBS	William J. Lindberg, Michael J. Marshall	15
20	Enzymes of glucose metabolism in carcinoma of the cervix and endometrium of the human uterus	British Journal of Cancer	Michael J. Marshall, David M. Goldberg et al.	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact